Los Angeles, CA -- (SBWIRE) -- 05/17/2019 -- Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
North America is the largest sales place, with a sales market share nearly 44.02% in 2017. Following North America, Europe is the second largest sales place with the sales market share of 29.45%.
The global Point-of-Care Testing (POCT) market was 17600 million US$ in 2018 and is expected to 36200 million US$ by the end of 2025, growing at a CAGR of 9.4% between 2019 and 2025.
Get PDF template of this report: https://www.qyresearch.com/sample-form/form/1089538/global-point-of-care-testing-poct-market
This report studies the Point-of-Care Testing (POCT) market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Point-of-Care Testing (POCT) in these regions, from 2014 to 2025, covering
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil etc.)
Middle East and Africa (Egypt and GCC Countries)
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
Roche
Abbott
Johnson & Johnson
Siemens Healthcare
Danaher
Ascensia
Bio-Rad Laboratories
BioMerieux
ARKRAY
Nova Biomedical
Trividia Health
Quidel
Accriva
OraSure Technologies
Helena Laboratories
A. Menarini Diagnostics
Abaxis (Zoetis)
Ortho Clinical Diagnostics
Phamatech
Chembio Diagnostics
Trinity Biotech
ELITech Group
Response Biomedical
Princeton BioMeditech
Alfa Wassermann
By the product type, the market is primarily split into
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Urinalysis Testing
Others
By the end users/application, this report covers the following segments
Clinics
Hospitals
Laboratory
Others
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
Get Full Report Now at USD 3,550 @ https://www.qyresearch.com/settlement/pre/ae6b94e0191ca8a781b72ea5ac6bacd4,0,1,Global%20Point-of-Care%20Testing%20(POCT)%20Market%20Report,%20History%20and%20Forecast%202014-2025,%20Breakdown%20Data%20by%20Manufacturers,%20Key%20Regions,%20Types%20and%20Application
About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in the consulting industry.